Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.
In the latest episode of the MedCity News Pivot Podcast, Heather Cox, President of Insights & Empowerment at Zelis, talked about the company's care coordination tools.
Zepbound's clinical tests in obstructive sleep apnea showed improvement in breathing disruptions that were accompanied by reductions in body weight. The new approval gives the Eli Lilly medicine the opportunity to become a blockbuster seller in yet another indication.
Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the company's Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach.
The best "gift" for a person with chronic conditions is the emotional support and education needed to stay adherent to medications during the hectic holiday season.
In this episode, we look at the reelection of Trump and how it will affect healthcare. We address the 340B drug discount program and the fact that J&J is suing the federal government over it. We also discuss how health systems in upstate New York are trying to provide pharmacy services given that many local pharmacies are shutting down.
No comments